Innovative ways to incorporate diverse populations in clinical trials

The participation of diverse populations is essential to ensure that clinical trials are inclusive, which should be a priority in medical research. Promoting the development of relationships between hospitals and research centres with diverse populations builds trust and awareness among group organisations and gives under-represented populations access to clinical trials.

Targets:

The inclusion of diverse populations in clinical trials is critical for drug companies, since the FDA requires that clinical trial subjects should be diverse. AstraZeneca is pursuing a range of innovative ways to enroll different patient populations in clinical trials.

Solutions:

Innovative solutions include, but are not limited to, cooperations with hospitals/research centers, databases, artificial intelligence, mobile devices, digital platforms and other types of health care organizations, or partnerships in other areas beyond health care and life sciences.